About
Convergent Radiotherapy and Radiosurgery is a medical start-up developing a new X-ray-focusing technology called MercyBeam. The companys patented technology uses a standard imaging X-ray source to form a converging beam into a volume of treatment, rather than the standard diverging one. This development is designed to render radiotherapy treatment more accurate and safe and to spare healthy organs and cells. MercyBeam introduces a lens that collects most of the X-rays emanating divergently out of any standard X-ray tube and converges themtoward the tumors location. The lens simultaneously removes low-energy photons that would be absorbed by the patients skin. The convergence increases the therapeutic dose delivered at the tumor location, while the organs in the vicinity of the tumor receive a very low dose or none at all. The converging technology enables the use of photon-energy X-rays 100 times lower than those used by current systems based on linear accelerators.
Funding history · 2 rounds · $3.7M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Convergent R.N.R.'s primary focus?
- Convergent R.N.R. is a medical startup developing MercyBeam, an X-ray focusing technology for cancer treatment designed to make radiotherapy more accurate and safer by sparing healthy organs and cells.
- When was Convergent R.N.R. founded?
- Convergent R.N.R. was founded in September 2010.
- What is the core technology developed by Convergent R.N.R.?
- Convergent R.N.R. has developed a patented X-ray focusing technology called MercyBeam, which uses a lens to converge X-rays from a standard imaging source towards a tumor, while simultaneously removing low-energy photons.
- How much funding has Convergent R.N.R. raised in total?
- Convergent R.N.R. has raised a total of $3,700,000 in funding. For a full financing history, please refer to startupim.
- When did Convergent R.N.R. secure its last known funding round?
- Convergent R.N.R. secured an undisclosed funding round in December 2017, raising $3,000,000.
- Which institution participated in Convergent R.N.R.'s Seed round?
- The Office of the Chief Scientist participated in Convergent R.N.R.'s Seed funding round.
- What significant alliance did Convergent R.N.R. establish in 2017?
- In June 2017, MD Anderson and Convergent R.N.R. Ltd. established an alliance to further develop new radiation technology with potentially fewer side effects.
- How many employees does Convergent R.N.R. currently have?
- Convergent R.N.R. currently has 17 employees.
- Who are the founders of Convergent R.N.R.?
- The founders of Convergent R.N.R. include Ze'ev Harel, Dr. Aharon Bar-David, Avigail Keller, and Zeev Burshtein.